Astragaloside IV ameliorates diabetic nephropathy in db/db mice by inhibiting NLRP3 inflammasome-mediated inflammation

Diabetic nephropathy (DN) is a primary cause of end-stage renal disease. Despite the beneficial effects of astragaloside IV (AS)-IV on renal disease, the underlying mechanism of its protective effects against DN has not been fully determined. The aims of the present study were to assess the effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Feng, Hui, Zhu, Xiaoyun, Tang, Yang, Fu, Shouqiang, Kong, Bingtan, Liu, Ximing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262660/
https://www.ncbi.nlm.nih.gov/pubmed/34278447
http://dx.doi.org/10.3892/ijmm.2021.4996

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262660/
https://www.ncbi.nlm.nih.gov/pubmed/34278447
http://dx.doi.org/10.3892/ijmm.2021.4996

Ejemplares similares